Michael Hallek to Mutation
This is a "connection" page, showing publications Michael Hallek has written about Mutation.
Connection Strength
0.229
-
Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence. Sci Rep. 2018 10 08; 8(1):14941.
Score: 0.044
-
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 06 21; 131(25):2745-2760.
Score: 0.042
-
Chronic lymphocytic leukaemia. Lancet. 2018 04 14; 391(10129):1524-1537.
Score: 0.042
-
Optimizing frontline therapy of CLL based on clinical and biological factors. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):338-345.
Score: 0.042
-
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription. Haematologica. 2020 05; 105(5):1379-1390.
Score: 0.012
-
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia. Nat Commun. 2018 02 20; 9(1):727.
Score: 0.011
-
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018 02 15; 9(1):697.
Score: 0.011
-
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome. Leuk Lymphoma. 2018 07; 59(7):1614-1623.
Score: 0.010
-
Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br J Haematol. 2017 09; 178(6):949-953.
Score: 0.010
-
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology. 2011 Jan 05; 409(1):77-83.
Score: 0.006